"The F.D.A. doesn't look at prices. Medicare is not allowed to look at prices. Commercial insurers are required by law, if they sell products, to cover cancer drugs. There was nobody else to do it, so we did.”
How Doctors Can Pressure Drug Companies to Lower Prices
One cancer drug was priced more than twice as much as a similar one. Memorial Sloan Kettering's doctors refused to prescribe the more expensive drug.
In 2012, the cancer drug Zaltrap cost on average $11,000 per month, more than twice as much as a similar medicine, Avastin.
After Memorial Sloan Kettering's doctors refused to prescribe the drug, its manufacturer halved the price. Sanofi, the maker of Zaltrap, realized that other cancer hospitals and doctors might follow suit.
Read the full article here.